Skip to main content
padlock icon - secure page this page is secure

Cyclophosphamide‐based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsE

Buy Article:

$59.00 + tax (Refund Policy)

Analysis of the efficiency and toxicity of cyclophosphamide‐based stem cell mobilization in patients with relapsed multiple myeloma (RMM).
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: bone marrow transplantation; clinical trials; multiple myeloma

Document Type: Research Article

Publication date: July 1, 2017

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more